Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-01-18
2005-01-18
Travers, Russell (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S417000, C548S476000, C548S472000, C548S477000, C548S479000
Reexamination Certificate
active
06844359
ABSTRACT:
Novel imides are inhibitors of tumor necrosis factor alpha and can be used to combat cachexia, endotoxic shock, and retrovirus replication. A typical embodiment is (R)-2-Phthalimido-3-(3′,4′-dimethoxyphenyl)propane.
REFERENCES:
F. Bachelerie et al. (Apr. 25, 1991)Nature, vol. 350, pp. 709-712.
Debajit K. Biswas et al. (1933)Journal of Acquired Immune Deficiency Syndromes, vol. 6, pp. 778-786.
Ghassan S. Dbaibo et al. (Aug. 25, 1993)The Journal of Biological Chemistry, vol. 265(24), pp. 17762-17766.
Elia J. Duh et al. (8/89)Proc. Natl. Acad. Sci. USA, vol. 86, pp. 5974-5978.
Alexander N. Shakhov et al. (1/90)J. Exp. Med., vol. 171, pp. 35-47.
Frank J.T. Staal et al. (12/90)Proc. Natl. Acad. Sci. USA, vol. 87, pp. 9943-9947.
Yuichiro J. Suzuki et al. (Dec. 30, 1992)Biochemical and Biophysical Research Communications, vol. 189(3), pp. 1709-1715.
Yuichiro J. Suzuki et al. (May 28, 1993)Biological and Biophysical Research Communications, vol. 193(1), pp. 277-283.
Yuichiro J. Suzuki et al. (11/93)Biochemistry and Molecular Biology International, vol. 31(4), pp. 693-700.
K. Sasaki et al. (9/94)Biological&Pharmaceutical Bulletin(of Japan) vol. 17, No. 9, pp. 1313-1315.
K. Sasaki et al. (9/95)Biological&Pharmaceutical Bulletin(of Japan) vol. 18, No. 9, pp. 1228-1233.
Database Crossfire, Beilstein Informationssysteme GmbH Frankfurt DE, SEE BRN=5086688.
Database Crossfire, Beilstein Informationssysteme GmbH Frankfurt DE, see BRN=1471607.
Database Crossfire, Beilstein Informationssysteme GmbH Frankfurt, DE see BRN=236720.
Muller George W.
Shire Mary
Stirling David I.
Celgene Corporation
Jones Day
Travers Russell
LandOfFree
Substituted imides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted imides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted imides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3386982